Ads
related to: Pfizer
Search results
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 15 hours agoWorries about waning effectiveness, though, have hammered Moderna stock. If approved, the vaccine...
The Smartest Dividend Stocks to Buy With $400 Right Now
Motley Fool via Yahoo Finance· 7 days agoI think so. The demand for oil and gas will likely grow even with increased renewable energy...
Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk (NYSE:PFE)
Seeking Alpha· 4 days agoAnalyst’s Disclosure: I/we have a beneficial long position in the shares of PFE, VKTX either through...
VC firm Canaan adds $100M-plus for biotech bets and tacks on a Pfizer vet to gauge early science
FierceBiotech· 3 days agoGeneral Partner Julie Grant told Fierce Biotech that the money will act as a designated pool for...
Lady Gaga's Migraine Saga
MediaPost· 2 days agoIn her second Nurtec ODT commercial, the singer focuses her camera on other migraine patients.
CEO Pay Rose to Another Record Last Year. Shareholders Did Even Better.
Barrons.com· 3 hours agoMedian pay for America’s top CEOs rose 11.4% in 2023 to a record $23.7 million, according to pay...
3 No-Brainer Stocks to Buy With $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoA modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 15 hours agoImage Source: Zacks Investment Research In the last five trading sessions, all the stocks were in...
Aaron Rodgers Suggests AIDS Was Created by U.S. Government
Metro Weekly· 1 day agoNew York Jets quarterback Aaron Rodgers stirred up a hornet’s nest when he made comments accusing...
A Win for the SEC on Shadow Trading. Now What?
The National Law Review· 4 days agoSince its outset, the SEC has tried to paint this like any other insider trading case – Panuwat, a senior executive at mid-sized oncology-focused...
